JP Morgan Chase’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-210,987
| Closed | -$325K | – | 7302 |
|
|
2021
Q4 | $325K | Buy |
210,987
+108,065
| +105% | +$178K | ﹤0.01% | 5084 |
|
|
2021
Q3 | $162K | Buy |
102,922
+57,073
| +124% | +$112K | ﹤0.01% | 5340 |
|
|
2021
Q2 | $121K | Buy |
+45,849
| New | +$85.4K | ﹤0.01% | 5481 |
|
|
2020
Q3 | – | Sell |
-114,827
| Closed | -$95K | – | 5934 |
|
|
2020
Q2 | $95K | Sell |
114,827
-341,584
| -75% | -$254K | ﹤0.01% | 4600 |
|
|
2020
Q1 | $330K | Sell |
456,411
-126,246
| -22% | -$141K | ﹤0.01% | 4046 |
|
|
2019
Q4 | $774K | Buy |
582,657
+549,239
| +1,644% | +$766K | ﹤0.01% | 4011 |
|
|
2019
Q3 | $47K | Buy |
33,418
+5,766
| +21% | +$11.5K | ﹤0.01% | 5206 |
|
|
2019
Q2 | $82K | Buy |
27,652
+8,491
| +44% | +$29.2K | ﹤0.01% | 5002 |
|
|
2019
Q1 | $72K | Sell |
19,161
-11,245
| -37% | -$35.7K | ﹤0.01% | 5001 |
|
|
2018
Q4 | $66K | Buy |
30,406
+12,215
| +67% | +$30.3K | ﹤0.01% | 4990 |
|
|
2018
Q3 | $49K | Sell |
18,191
-16,885
| -48% | -$59.7K | ﹤0.01% | 5202 |
|
|
2018
Q2 | $149K | Buy |
35,076
+22,193
| +172% | +$83.4K | ﹤0.01% | 4689 |
|
|
2018
Q1 | $47K | Sell |
12,883
-922
| -7% | -$3.42K | ﹤0.01% | 4843 |
|
|
2017
Q4 | $52K | Buy |
+13,805
| New | +$55.3K | ﹤0.01% | 4886 |
|
|
2017
Q2 | – | Sell |
-27,780
| Closed | -$101K | – | 5331 |
|
|
2017
Q1 | $101K | Sell |
27,780
-3,976
| -13% | -$14K | ﹤0.01% | 4326 |
|
|
2016
Q4 | $157K | Buy |
+31,756
| New | +$144K | ﹤0.01% | 4262 |
|
|
2016
Q3 | – | Sell |
-861
| Closed | -$3K | – | 4921 |
|
|
2016
Q2 | $3K | Hold |
861
| – | – | ﹤0.01% | 4569 |
|
|
2016
Q1 | $3K | Buy |
861
+675
| +363% | +$2.22K | ﹤0.01% | 4480 |
|
|
2015
Q4 | $1K | Buy |
+186
| New | +$799 | ﹤0.01% | 4638 |
|
|
2015
Q3 | – | Sell |
-427,640
| Closed | -$3.48M | – | 4149 |
|
|
2015
Q2 | $3.48M | Buy |
427,640
+36,485
| +9% | +$304K | ﹤0.01% | 2603 |
|
|
2015
Q1 | $3.04M | Buy |
391,155
+100,692
| +35% | +$862K | ﹤0.01% | 2650 |
|
|
2014
Q4 | $3.4M | Sell |
290,463
-35,563
| -11% | -$424K | ﹤0.01% | 2649 |
|
|
2014
Q3 | $4.22M | Buy |
326,026
+132,292
| +68% | +$1.75M | ﹤0.01% | 2480 |
|
|
2014
Q2 | $2.94M | Buy |
193,734
+137,209
| +243% | +$2.23M | ﹤0.01% | 2341 |
|
|
2014
Q1 | $1.2M | Buy |
+56,525
| New | +$1.64M | ﹤0.01% | 2773 |
|
JP Morgan Chase's CSLT Position: Q1 2022 in Review
JP Morgan Chase sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 210,987 shares — an estimated $325K sold.
JP Morgan Chase first reported a position in CSLT in Q1 2014 and held it in 25 quarters. The position peaked at $4.22M in Q3 2014. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.
- JP Morgan Chase reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
- JP Morgan Chase sold 210,987 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $325K.
- JP Morgan Chase first reported a position in CASTLIGHT HEALTH, INC. in Q1 2014 and held it in 25 quarters.
- JP Morgan Chase's CASTLIGHT HEALTH, INC. position peaked at $4.22M in Q3 2014.
- 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.
Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.